Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Velardi

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
The EMBO Journal|May 1, 1993
Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicleJ D Vassalli, J Huarte, D Bosco, et al.
Bone Marrow Transplantation|December 6, 2011
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCTK Perruccio, F Topini, A Tosti, et al.
Blood|April 6, 2001
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI Volpi, K Perruccio, A Tosti, et al.
Blood|October 1, 1989
Lymphokine production by T-cell clones after human bone marrow transplantationA Velardi, P Varese, A Terenzi, et al.
Blood|March 15, 1990
Cytolytic function of clonable T cells after human bone marrow transplantationA Velardi, P Varese, C E Grossi, et al.
Leukemia|August 22, 2015
Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?O Ringdén, M Labopin, F Ciceri, et al.
Haematologica|February 9, 1999
Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cellsD Zarcone, G De Rossi, C Tenca, et al.
The New England Journal of Medicine|October 22, 1998
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotypeF Aversa, A Tabilio, A Velardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2016
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationS Genadieva-Stavrik, A Boumendil, P Dreger, et al.
Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
The EMBO Journal|May 1, 1993
Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicleJ D Vassalli, J Huarte, D Bosco, et al.
Bone Marrow Transplantation|December 6, 2011
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCTK Perruccio, F Topini, A Tosti, et al.
Blood|April 6, 2001
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI Volpi, K Perruccio, A Tosti, et al.
Blood|October 1, 1989
Lymphokine production by T-cell clones after human bone marrow transplantationA Velardi, P Varese, A Terenzi, et al.
Blood|March 15, 1990
Cytolytic function of clonable T cells after human bone marrow transplantationA Velardi, P Varese, C E Grossi, et al.
Leukemia|August 22, 2015
Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?O Ringdén, M Labopin, F Ciceri, et al.
Haematologica|February 9, 1999
Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cellsD Zarcone, G De Rossi, C Tenca, et al.
The New England Journal of Medicine|October 22, 1998
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotypeF Aversa, A Tabilio, A Velardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2016
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationS Genadieva-Stavrik, A Boumendil, P Dreger, et al.
Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.
Pageof 11